This pregnancy was notable for an abnormal alpha fetoprotein and triple screen, which was followed with serial ultrasounds.
The mother presented to her [**Name (NI) **] office on the day of delivery showing poor fetal growth and reported leaking of amniotic fluid for two months.
She underwent a cesarean section for concern for fetal heart rate decelerations.
The baby required blow by O2, drying and bulb suctioning.
He was admitted to the Neonatal Intensive Care Unit for management of his prematurity.
He was extubated to nasal cannula O2 on day of life number one.
He remained on nasal cannula O2 until day of life number twenty five when due to increased work of breathing he was placed on nasopharyngeal CPAP.
Since that time he has remained on high flow nasal cannula O2 400 to 500 cc of flow, 45 to 65% fraction of inspired oxygen.
He required treatment with Dopamine through day of life number nine.
Fluids, electrolytes and nutrition:  [**Known lastname 43153**] was initially NPO and maintained on intravenous fluids.
He required monitoring with an umbilical arterial catheter for the first two weeks of life.
Enteral feeds were started on day of life number ten and gradually advanced to full volume.
At the time of discharge he is on mother's breast milk fortified to 34 calories per ounce, 4 with human milk fortifier, 6 by calories by medium chain triglyceride oil and 4 calories by Polycose.
He is on sodium, potassium, chloride and potassium phosphate supplements.
He received a seven day course of Ampicillin and Gentamycin.
Due to prior concern for sepsis [**Known lastname 43153**] was being treated with Vancomycin and Gentamycin.
His coverage was changed to include Ceftazidime to provide better coverage.
A second incision and drainage was performed on [**2152-7-28**] and again the same Citrobacter koseri was cultured.
He received a total of fourteen days of the Vancomycin, Gentamycin and Ceftazidime with resolution of the abscess.
The only metabolic test found to be abnormal was the carnitine panel with his level slightly low, carnitine replacement therapy was started and his most recent carnitine levels were on [**2152-8-15**].
He has been treated with both Phenobarbital and Actigall.
He has received multiple transfusions of packed red blood cells.
He is receiving supplemental iron.
He responds with intermittent blood glucoses less then 40.
It does not appear to be a result of hyperinsulism and may explain his poor growth.
Neurology:  Head ultrasound has been performed on two occasions during his admission.
One half teaspoon ProMod powder per 100 cc of the breast milk.
MEDICATIONS:  Ranitidine 4.8 mg po q 8 hours, Carnitine 100 mg po b.i.d., potassium phosphate 2.3 millimoles po b.i.d., vitamin D 300 international units po q day, calcium glubionate 46 mg as elemental calcium po b.i.d., Reglan 0.2 mg po q 8 hours administered one half hour prior to feeds.
Fer-In-[**Male First Name (un) **] 25 mg per ml dilution 0.25 cc po q.d., Diuril 43 mg po pg b.i.d., sodium chloride supplement 1 milliequivalent po b.i.d., potassium chloride supplement 1 milliequivalent po b.i.d., Actigall 30 mg po b.i.d., vitamin E 5 international units po q day.
Immunizations were administered between [**8-8**] and [**2152-8-12**] and included hepatitis B vaccine, diptheria, cellular pertussis, hemophilus influenza, the injectable polio vaccine and the pneumococcal seven valent conjugate vaccine.
Immunizations recommended, Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria - born at less then 32 weeks gestation, born between 32 and 35 weeks with plans for day care during RSV season, with a smoker in the household or with preschool siblings or with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other care givers should be considered for immunization against influenza to protect the infant.
